Haemonetics Corporation (HAE)

NYQ – Real Time Price. Currency in USD

90.10

+2.88 (3.30%)

Market open: Aug 12, 2026, 3:21 PM EDT

87.22

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

11.08.2026

Haemonetics (HAE) Reliance on International Sales: What Investors Need to Know

Examine Haemonetics' (HAE) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

08.08.2026

Haemonetics Q1 Earnings Call Highlights

Haemonetics NYSE: HAE reported a stronger start to fiscal 2027, with first-quarter revenue rising 6% year over year to $339 million and adjusted diluted earnings per share increasing 4% to $1.14. The company raised its full-year revenue outlook, citing broad-based growth across its MedSurg and apheresis businesses, while maintaining a disciplined stance on assumptions for the remainder of the year.

06.08.2026

Haemonetics Corporation (HAE) Q1 2027 Earnings Call Transcript

06.08.2026

Haemonetics (HAE) Tops Q1 Earnings and Revenue Estimates

Haemonetics (HAE) came out with quarterly earnings of $1.14 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $1.1 per share a year ago.

06.08.2026

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

Financial release and supplemental presentation accessible online BOSTON, Aug. 6, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2027, which ended June 27, 2026, are available on the Company's Investor Relations website at www.haemonetics.com. The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m.

03.08.2026

New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths

BOSTON, Aug. 3, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced publication of a study providing new evidence supporting the safety and efficacy of Haemonetics' VASCADE MVP ® XL venous vascular closure system in large-bore sheath procedures. The retrospective cohort study represents the largest reported cohort using the VASCADE MVP XL system to date.

Videos

No Data

There is no data to display

Press releases

06.08.2026

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

03.08.2026

Haemonetics Corporation (HAE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Haemonetics Corporation (HAE)

Haemonetics (HAE) Reliance on International Sales: What Investors Need to Know

Haemonetics Q1 Earnings Call Highlights

Haemonetics Corporation (HAE) Q1 2027 Earnings Call Transcript

Haemonetics (HAE) Tops Q1 Earnings and Revenue Estimates

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths

Videos

No Data

Press releases

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths

Haemonetics (HAE) Reliance on International Sales: What Investors Need to Know

Haemonetics Q1 Earnings Call Highlights

Haemonetics Corporation (HAE) Q1 2027 Earnings Call Transcript

Haemonetics (HAE) Tops Q1 Earnings and Revenue Estimates

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths

Videos

No Data

Press releases

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths

Search stocks

Haemonetics Corporation (HAE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Haemonetics Corporation (HAE)

Haemonetics (HAE) Reliance on International Sales: What Investors Need to Know

Haemonetics Q1 Earnings Call Highlights

Haemonetics Corporation (HAE) Q1 2027 Earnings Call Transcript

Haemonetics (HAE) Tops Q1 Earnings and Revenue Estimates

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths

Videos

No Data

Press releases

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths

Haemonetics (HAE) Reliance on International Sales: What Investors Need to Know

Haemonetics Q1 Earnings Call Highlights

Haemonetics Corporation (HAE) Q1 2027 Earnings Call Transcript

Haemonetics (HAE) Tops Q1 Earnings and Revenue Estimates

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths

Videos

No Data

Press releases

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths